BLT 0.00% 2.6¢ benitec biopharma limited

Ann: BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX, page-6

  1. J8
    14,558 Posts.
    lightbulb Created with Sketch. 826
    I'm very happy that the trial was closed because of financial reason in the HCV market place. It is quite obvious now, that the fact that it didn't work AT ALL, had nothing to do with stopping the trial. I'm also very happy that the market knows and the SP shows.......... but we are the last to know.

    What a huge load of bollocks.

    Don't worry folks: the new model will work fine. You just wait (ten years) and see.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.